Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin. 2021; 71: 209-249
- Foulkes W.D.
- Smith I.E.
- Reis-Filho J.S.
Triple-negative breast cancer.N Engl J Med. 2010; 363: 1938-1948
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.J Clin Invest. 2011; 121: 2750-2767
Cancer stem cells: an evolving concept.Nat Rev Cancer. 2012; 12: 133-143
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer.Nat Commun. 2018; 9: 2897
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells.Nature. 2015; 526: 131-135
Targeting the Roots of Recurrence: New Strategies for Eliminating Therapy-Resistant Breast Cancer Stem Cells.Cancers (Basel). 2020; 13
- Faubert B.
- Solmonson A.
- DeBerardinis R.J.
Metabolic reprogramming and cancer progression.Science. 2020; 368
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.Nature. 2008; 452: 230-233
- Vander Heiden M.G.
- Cantley L.C.
- Thompson C.B.
Understanding the Warburg effect: the metabolic requirements of cell proliferation.Science. 2009; 324: 1029-1033
Tumor-secreted dickkopf2 accelerates aerobic glycolysis and promotes angiogenesis in colorectal cancer.Theranostics. 2019; 9: 1001-1014
CAB39L elicited an anti-Warburg effect via a LKB1-AMPK-PGC1α axis to inhibit gastric tumorigenesis.Oncogene. 2018; 37: 6383-6398
- Arizmendi-Izazaga A.
- et al.
Metabolic Reprogramming in Cancer: Role of HPV 16 Variants.Pathogens. 2021; 10
Targeting cancer metabolism: a therapeutic window opens.Nat Rev Drug Discov. 2011; 10: 671-684
MYC-induced cancer cell energy metabolism and therapeutic opportunities.Clin Cancer Res. 2009; 15: 6479-6483
MYC on the path to cancer.Cell. 2012; 149: 22-35
USP22 exerts tumor-suppressive functions in colorectal cancer by decreasing mTOR activity.Cell Death Differ. 2020; 27: 1328-1340
USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1α/USP22 positive feedback loop upon TP53 inactivation.Gut. 2020; 69: 1322-1334
USP22 regulates oncogenic signaling pathways to drive lethal cancer progression.Cancer Res. 2014; 74: 272-286
Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer.J Surg Oncol. 2011; 103: 283-289
Hypoxia-induced USP22-BMI1 axis promotes the stemness and malignancy of glioma stem cells via regulation of HIF-1α.Life Sci. 2020; 247117438
Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer.J Cancer Res Clin Oncol. 2011; 137: 1245-1253
USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response.Oncogene. 2021; 40: 4004-4018
- Livak K.J.
- Schmittgen T.D.
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.Methods. 2001; 25: 402-408
- Venkatesh J.
- Rishi A.K.
- Reddy K.B.
Novel strategies to target chemoresistant triple-negative breast cancer.Genes Cancer. 2020; 11: 95-105
ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays.J Immunol Methods. 2009; 347: 70-78
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).Eur J Cancer. 2009; 45: 228-247
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.Oncogene. 2010; 29: 4741-4751
STAT3 as a promising chemoresistance biomarker associated with the CD44(+/high)/CD24(-/low)/ALDH(+) BCSCs-like subset of the triple-negative breast cancer (TNBC) cell line.Exp Cell Res. 2018; 363: 283-290
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities.Cancer Metab. 2017; 5: 6
Ubiquitin-specific peptidase 22 in cancer.Cancer Lett. 2021; 514: 30-37
- Fillmore C.M.
- Kuperwasser C.
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.Breast Cancer Res. 2008; 10: R25
Eradication of cancer stem cells in triple negative breast cancer using doxorubicin/pluronic polymeric micelles.Nanomedicine. 2020; 24102124
Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.Lung Cancer. 2012; 77: 593-599
Significance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguity.Clin Dev Immunol. 2012; 2012708036
- Pastushenko I.
- Blanpain C.
EMT Transition States during Tumor Progression and Metastasis.Trends Cell Biol. 2019; 29: 212-226
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities.Front Med. 2018; 12: 361-373
USP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinoma.Lung Cancer. 2015; 88: 239-245
Operative ubiquitin-specific protease 22 deubiquitination confers a more invasive phenotype to cholangiocarcinoma.Cell Death Dis. 2021; 12: 678
Interplay between Metabolism Reprogramming and Epithelial-to-Mesenchymal Transition in Cancer Stem Cells.Cancers (Basel). 2021; 13
Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells.J Clin Invest. 2019; 129: 1030-1046
Glucose oxidation modulates anoikis and tumor metastasis.Mol Cell Biol. 2012; 32: 1893-1907
- Martinez-Outschoorn U.E.
- et al.
Ketones and lactate increase cancer cell "stemness," driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-Genomics.Cell Cycle. 2011; 10: 1271-1286
USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity.Cancer Immunol Res. 2019; 7: 1580-1590
USP22 acts as an oncogene by regulating the stability of cyclooxygenase-2 in non-small cell lung cancer.Biochem Biophys Res Commun. 2015; 460: 703-708
MYC, metabolism, cell growth, and tumorigenesis.Cold Spring Harb Perspect Med. 2013; 3
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc.Nat Commun. 2019; 10: 3499
mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc.Cell Metab. 2013; 18: 726-739
Deubiquitinating enzyme USP22 positively regulates c-Myc stability and tumorigenic activity in mammalian and breast cancer cells.J Cell Physiol. 2017; 232: 3664-3676